Joseph HULIHAN

Person

Radnor, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Ganaxolone for use in treating tuberous sclerosis complex and seizu...
- Patent number 12,115,169
- Issue date Oct 15, 2024
- MARINUS PHARMACEUTICALS, INC.
- Joseph Hulihan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ganaxolone for use in treating tuberous sclerosis complex
- Patent number 11,980,625
- Issue date May 14, 2024
- MARINUS PHARMACEUTICALS, INC.
- Alex Aimetti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ganaxolone for use in treating tuberous sclerosis complex
- Patent number 11,701,367
- Issue date Jul 18, 2023
- MARINUS PHARMACEUTICALS, INC.
- Alex Aimetti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ganaxolone for use in treatment of status epilepticus
- Patent number 11,679,117
- Issue date Jun 20, 2023
- MARINUS PHARMACEUTICALS, INC.
- David Czekai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ganaxolone for use in treatment of status epilepticus
- Patent number 11,110,100
- Issue date Sep 7, 2021
- MARINUS PHARMACEUTICALS, INC.
- David Czekai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
GANAXOLONE FOR USE IN TREATING TUBEROUS SCLEROSIS COMPLEX
- Publication number 20240374614
- Publication date Nov 14, 2024
- MARINUS PHARMACEUTICALS, INC.
- Alex AIMETTI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GANAXOLONE FOR USE IN TREATMENT OF ESTABLISHED STATUS EPILEPTICUS
- Publication number 20240245709
- Publication date Jul 25, 2024
- MARINUS PHARMACEUTICALS, INC.
- Henrikas VAITKEVICIUS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GANAXOLONE FOR USE IN TREATING TUBEROUS SCLEROSIS COMPLEX AND SEIZU...
- Publication number 20240173336
- Publication date May 30, 2024
- Marinus Pharmaceuticals Inc.
- Joseph HULIHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GANAXOLONE FOR USE IN TREATING TUBEROUS SCLEROSIS COMPLEX
- Publication number 20240100067
- Publication date Mar 28, 2024
- MARINUS PHARMACEUTICALS, INC.
- Alex AIMETTI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS
- Publication number 20230405021
- Publication date Dec 21, 2023
- MARINUS PHARMACEUTICALS, INC.
- David CZEKAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GANAXOLONE FOR USE IN TREATMENT OF SUPER REFRACTORY STATUS EPILEPTICUS
- Publication number 20230364109
- Publication date Nov 16, 2023
- MARINUS PHARMACEUTICALS, INC.
- Henrikas VAITKEVICIUS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF GANAXOLONE IN TREATING AN EPILEPSY DISORDER
- Publication number 20230321117
- Publication date Oct 12, 2023
- MARINUS PHARMACEUTICALS, INC.
- Alex Aimetti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS
- Publication number 20220265680
- Publication date Aug 25, 2022
- MARINUS PHARMACEUTICALS, INC.
- David CZEKAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GANAXOLONE FOR USE IN TREATING TUBEROUS SCLEROSIS COMPLEX
- Publication number 20220211723
- Publication date Jul 7, 2022
- MARINUS PHARMACEUTICALS, INC.
- Alex AIMETTI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS
- Publication number 20220202831
- Publication date Jun 30, 2022
- MARINUS PHARMACEUTICALS, INC.
- David CZEKAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS
- Publication number 20210186987
- Publication date Jun 24, 2021
- MARINUS PHARMACEUTICALS, INC.
- David CZEKAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Joseph HULIHAN

Person

Patents Grantslast 30 patents

Ganaxolone for use in treating tuberous sclerosis complex and seizu...

Ganaxolone for use in treating tuberous sclerosis complex

Ganaxolone for use in treating tuberous sclerosis complex

Ganaxolone for use in treatment of status epilepticus

Ganaxolone for use in treatment of status epilepticus

Patents Applicationslast 30 patents

GANAXOLONE FOR USE IN TREATING TUBEROUS SCLEROSIS COMPLEX

GANAXOLONE FOR USE IN TREATMENT OF ESTABLISHED STATUS EPILEPTICUS

GANAXOLONE FOR USE IN TREATING TUBEROUS SCLEROSIS COMPLEX AND SEIZU...

GANAXOLONE FOR USE IN TREATING TUBEROUS SCLEROSIS COMPLEX

GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS

GANAXOLONE FOR USE IN TREATMENT OF SUPER REFRACTORY STATUS EPILEPTICUS

USE OF GANAXOLONE IN TREATING AN EPILEPSY DISORDER

GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS

GANAXOLONE FOR USE IN TREATING TUBEROUS SCLEROSIS COMPLEX

GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS

GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS